Session 2 Trial Designs For

Friends of Cancer Research Annual Meeting 2025 will spotlight pressing topics at the forefront of cancer research and regulation, ...

... what we were attempting to do with the

... the

In this video discussion, we explain the essential concepts of clinical

Session

In June 2023, FDA issued its first psychedelics draft guidance for industry, Psychedelic Drugs: Considerations for Clinical ...

Learn the essential principles behind rigorous clinical research that supports FDA drug approvals. This video covered the key ...

In this video we look at

Jörn Schattenberg and Naim Alkhouri join the Surfers (including NASH-TAG co-director Stephen Harrison) to review NASH-TAG ...

Scott Berry convenes co-authors Kert Viele, Joe Marion, and Lindsay Berry to discuss the statistical and developmental nuances ...

Richard L. Schilsky, MD.

'Study

Session 2

BRIAN CORRIGAN Senior Director Pfizer.

PRECIS is a tool to help trialists make

The “Innovative phase III randomised clinical

The

This presentation explained the concept of Selective Safety Data Collection (SSDC) and its application in clinical

Air date: Saturday, January 22, 2022, 12PM Sample Size and Power: Phase

NAMSA Insight